OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1235
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Ectodermal dysplasia-absent dermatoglyphs syndrome, also known as Basan syndrome or ectodermal dysplasia with absent dermatoglyphics, is an extremely rare genetic condition characterized by the congenital absence of dermatoglyphics (fingerprints and other skin ridge patterns on the hands and feet) combined with features of ectodermal dysplasia. This condition primarily affects the skin and its appendages. Key clinical features include absent or reduced fingerprints (adermatoglyphia), facial milia (small white cysts on the skin, particularly the face) that may appear in infancy and resolve over time, and blistering of the skin, especially on the hands and feet. Some affected individuals may also have nail abnormalities and reduced sweating. The condition is present from birth, with blistering often noted in the neonatal period. This entry is marked as OBSOLETE in Orphanet, suggesting it may have been reclassified or merged with another condition. The phenotype overlaps with what has been described as adermatoglyphia or 'immigration delay disease,' and some cases may now be classified under SMARCAD1-related conditions. The syndrome was first described by Basan in 1965 in a large family. There is no specific treatment for this condition; management is supportive and focuses on skin care, prevention of blistering, and monitoring of ectodermal features. Genetic counseling is recommended for affected families.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome community →

No specialists are currently listed for OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndromeForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome.

Start the conversation →

Latest news about OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome

No recent news articles for OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome

What is OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome?

Ectodermal dysplasia-absent dermatoglyphs syndrome, also known as Basan syndrome or ectodermal dysplasia with absent dermatoglyphics, is an extremely rare genetic condition characterized by the congenital absence of dermatoglyphics (fingerprints and other skin ridge patterns on the hands and feet) combined with features of ectodermal dysplasia. This condition primarily affects the skin and its appendages. Key clinical features include absent or reduced fingerprints (adermatoglyphia), facial milia (small white cysts on the skin, particularly the face) that may appear in infancy and resolve over

How is OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome inherited?

OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome typically begin?

Typical onset of OBSOLETE: Ectodermal dysplasia-absent dermatoglyphs syndrome is neonatal. Age of onset can vary across affected individuals.